Neogen (NEOG) Earnings Analysis
Neogen (NEOG) next reports earnings on 2026-07-30, consensus EPS 0.05 USD. Last quarter (2026-04-09) it beat with EPS 0.09 USD vs 0.04 USD est (+125%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -3.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NEOG next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.05 USD |
| Revenue estimate | 0.21B |
NEOG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-09 | 0.09 USD | 0.04 USD | +125% | Beat |
| 2026-01-08 | 0.1 USD | 0.07 USD | +42.9% | Beat |
| 2025-10-09 | 0.04 USD | -0.074 USD | +154.1% | Beat |
| 2025-04-09 | 0.1 USD | 0.13 USD | -23.1% | Miss |
| 2025-01-10 | 0.11 USD | 0.09 USD | +22.2% | Beat |
| 2024-10-10 | 0.07 USD | 0.085 USD | -17.6% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
NEOG valuation and analyst view
| Trailing P/E | -3.51 |
|---|---|
| Trailing EPS | -2.79643 USD |
| Price / book | 1.02 |
| Dividend yield | 0.00% |
| Market cap | 2.14B |
| Analyst consensus | Hold (4 buy / 6 hold / 1 sell) |
| Avg price target | 9.5 USD |
Related research pages
Frequently asked questions
When is Neogen (NEOG)'s next earnings date?
Neogen is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.05 USD and revenue estimate of 0.21B.
Did NEOG beat earnings last quarter?
In its 2026-04-09 report, NEOG posted EPS of 0.09 USD versus a 0.04 USD estimate — a beat of 125%.
What is NEOG's earnings track record?
Over the last 6 reported quarters with consensus data, NEOG beat estimates 4 times (67%).
What is NEOG's current P/E ratio and EPS?
NEOG trades at a trailing P/E of -3.51 on trailing EPS of -2.7964262746899404 USD.
What do analysts rate NEOG?
Analyst consensus is "Hold" across 11 ratings (0 strong buy, 4 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 9.5 USD.